SBS Code
stringlengths 9
11
| SBS Code (Hyphenated)
stringlengths 11
12
| Short Description
stringlengths 3
74
| Long Description
stringlengths 7
544
| Chapter
float64 1
25
⌀ | Chapter Name
stringclasses 25
values | Block
int64 1
4.02k
| Block Name
stringlengths 3
99
⌀ | Definition
stringlengths 11
1.18k
⌀ | Includes
stringlengths 4
1.31k
⌀ | Excludes
stringlengths 1
1.23k
⌀ | Guidelines
stringlengths 1
1.54k
⌀ |
|---|---|---|---|---|---|---|---|---|---|---|---|
731000170
|
73100-01-70
|
Reticulated platelets
|
Measurement of Reticulated Platelets
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Assay for determining percentage of reticulated platelets
| null | null | null |
731000180
|
73100-01-80
|
Interpretationperipheral blood smear
|
Physician Interpretation of peripheral blood smear with written report
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Physician review, interpertation, and examination report of peripheral blood smear
| null | null | null |
731000190
|
73100-01-90
|
Interpretationbone marrow smear
|
Interpretation of Bone Marrow smear
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Physician interpertation of bone marrow smear
| null | null | null |
731000200
|
73100-02-00
|
Chromogenic
|
Chromogenic substrate assay
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of blood thinner concentration (e.g. Heparin, fondaparinux)
| null | null | null |
731000210
|
73100-02-10
|
Clot retraction
|
Clot retraction test
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of amount of serum and red blood cells in a blood clot
| null | null | null |
731000220
|
73100-02-20
|
Diluted Whole Blood Clotting test (dWBCT)
|
Clot lysis time of whole blood dilution
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of clot break down time
| null | null | null |
731000230
|
73100-02-30
|
Clotting factor II (Prothrombin)
|
Measurement of clotting factor II (Prothrombin)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of coagulation Factor II (Prothrombin) presence (e.g. Liver diseases, Vitamin K deficency, anticoagulation therapy evaluation, prolonged prothrombin time)
| null | null | null |
731000240
|
73100-02-40
|
Clotting factor V (Proaccelerin)
|
Measurement of clotting factor V [Proaccelerin, labile factor, accelerator globulin (AcG)]
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of coagulation Factor V (Proaccelerin) presence (e.g. liver disease, myeloproliferative disorders)
| null | null | null |
731000250
|
73100-02-50
|
Clotting factor VII (Proconvertin)
|
Measurement of clotting factor VII (Proconvertin, stable factor)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of coagulation Factor VII (Proconvertin) presence (e.g. Liver diseases, Vitamin K deficency, anticoagulation therapy evaluation, prolonged prothrombin time)
| null | null | null |
731000260
|
73100-02-60
|
Clotting factor VIII (AHG)
|
Measurement of clotting factor VIII (AHG), 1-stage
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of coagulation Factor VIII (AHG) presence (e.g. hemophilia A, CF VII Deficency, Willebrand disease)
| null | null | null |
731000270
|
73100-02-70
|
Clotting factor VIII Ag
|
Measurement of clotting factor VIII related antigens (VIII;Ag)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of coagulation Factor VIII (AHG) related antigen presence in patient serum
| null | null | null |
731000280
|
73100-02-80
|
VWF-R Co factor
|
Measurement of clotting factor VIII [von willebrand factor (vWF)] activity, ristocetin cofactor test
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Assay for coagulation factor (VIII/von Willebrand factor) via ristocetin to measure platelet aggregation (e.g. to diagnose hemophilia A or von Willebrand’s disease )
| null | null | null |
731000290
|
73100-02-90
|
VWF antigen
|
Measurement of clotting factor VIII [von Willebrand factor (vWF)] antigen
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of coagulation factor (VIII/von Willebrand factor) Antigens (e.g. to diagnose von Willebrand disease and its types)
| null | null | null |
731000300
|
73100-03-00
|
VWF-Multimetric
|
Measurement of clotting factor VIII [von Willebrand factor (vWF)] with Multimeric analysis
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Multimetric analysis for coagulation factor (VIII/von Willebrand factor) to evaluate VWF subtypes
| null | null | null |
731000310
|
73100-03-10
|
Clotting factor IX (PTC)
|
Measurement of clotting factor IX (PTC; Christmas)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of coagulation Factor IX presence (e.g. hemophilia B, Christmas disease)
| null | null | null |
731000320
|
73100-03-20
|
Clotting factor X
|
Measurement of clotting factor X (Stuart-Prower)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of coagulation Factor X presence (e.g. liver disease or vitamin K deficiency)
| null | null | null |
731000330
|
73100-03-30
|
Clotting factor XI (PTA)
|
Measurement of clotting factor XI (plasma thromboplastin antecendent (PTA))
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of coagulation Factor XI presence (e.g. hemophilia C)
| null | null | null |
731000340
|
73100-03-40
|
Clotting factor XII
|
Measurement of clotting factor XII (Hageman)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of coagulation Factor XII (Hageman) presence
| null | null | null |
731000350
|
73100-03-50
|
Clotting factor XIII
|
Measurement of clotting factor XIII (fibrin stabilizing)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of coagulation Factor XIII presence (e.g. bleeding disorders with normal PT;PTT)
| null | null | null |
731000360
|
73100-03-60
|
Clotting factor XIII Solubility Screen
|
Solubility screening for clotting factor XIII (fibrin stabilizing)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Solubility screening test for determination of coagulation Factor XIII presence
| null | null | null |
731000370
|
73100-03-70
|
Fletcher factor
|
Measurement of Fletcher factor (Plasma Prekallikrein)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Clotting assay for presence of fletcher factor (plasma prekallikrein)
| null | null | null |
731000380
|
73100-03-80
|
Fitzgerald factor
|
Measurement of high molecular weight kininogen (Fitzgerald factor assay)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Clotting assay for presence of fitzgerald factor
| null | null | null |
731000390
|
73100-03-90
|
Antithrombin III activity
|
Measurement of anticoagulant (Antithrombin III)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of clotting inhibitor Antithrombin III activity [e.g.deep vein thrombosis (DVT), pulmonary embolism (PE)].
| null | null | null |
731000400
|
73100-04-00
|
Antithrombin III antigen
|
Measurement of anticoagulant (Antithrombin III) antigens
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of clotting inhibitor Antithrombin III antigens [e.g.deep vein thrombosis (DVT), pulmonary embolism (PE)].
| null | null | null |
731000410
|
73100-04-10
|
Protein C antigen
|
Measurement of anticoagulant (Protein C) antigens
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of clotting inhibitor Protein C antigens (e.g. congenital or acquired protein C deficiency)
| null | null | null |
731000420
|
73100-04-20
|
Protein C activity
|
Measurement of anticoagulant (Protein C) Activity
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of clotting inhibitor Protein C activity (e.g. congenital or acquired protein C deficiency)
| null | null | null |
731000430
|
73100-04-30
|
Total protein S
|
Measurement of anticoagulant (Total Protein S) Levels
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of clotting inhibitor total Protein S levels (e.g. congenital or acquired protein S deficiency)
| null | null | null |
731000440
|
73100-04-40
|
Free protein S
|
Measurement of anticoagulant (Free Protein S) Levels
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of clotting inhibitor free Protein S levels (e.g. congenital or acquired protein S deficiency)
| null | null | null |
731000450
|
73100-04-50
|
APC resistance
|
Measurement of Activated Protein C (APC) resistance
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Active Protein C resistance (e.g. venous thromboembolism, arterial thrombosis, recurrent miscarriage)
| null | null | null |
731000460
|
73100-04-60
|
Factor inhibitor
|
Factor inhibitor assay
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Quantification of coagulation factor inhibitor after positive screen results for any of the other coagulation factors.
| null | null | null |
731000470
|
73100-04-70
|
Thrombomodulin levels
|
Measurement of thrombomodulin (TM; endothelial cofactor)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Thrombomodulin plasma levels (e.g. SLE, cancers, disseminated intravascular coagulation, pulmonary thromboembolism, kidney damage, thrombotic thrombocytopenic purpura).
| null | null | null |
731000480
|
73100-04-80
|
LW clotting time
|
Lee and White clotting time test
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Clot formation time by Lee and White method (e.g. monitoring of anticoagulant therapy effect)
| null | null | null |
731000490
|
73100-04-90
|
ACT test
|
Activated clotting time (ACT) test
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Clot formation time by physical activation method (e.g. monitoring of anticoagulant therapy effect)
| null | null | null |
731000500
|
73100-05-00
|
Other clotting time test
|
Other clotting time test
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Clot formation time by other specified methods
| null | null | null |
731000510
|
73100-05-10
|
Euglobulin lysis time
|
Euglobulin Lysis time Test
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of euglobulin clot breakdown time by other specified methods (e.g. fibrinolytic activity)
| null | null | null |
731000520
|
73100-05-20
|
FDP test; SemiQuantitative
|
SemiQuantitative analysis of fibrin degradation/split products (FDP; FSP) using agglutination slide method
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of fibrinogen break down products via slide agglutination method (e.g. disseminated intravascular coagulation)
| null | null | null |
731000530
|
73100-05-30
|
Paracoagulation FDP test
|
Paracoagulation test for fibrin degradation/split products (FDP; FSP)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of fibrinogen break down products via paracoagulation test (e.g. disseminated intravascular coagulation)
| null | null | null |
731000540
|
73100-05-40
|
FDP test; Quant.
|
Quantitative test for fibrin degradation/split products (FDP; FSP)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Quantatative evaluation of fibrinogen break down products
| null | null | null |
731000550
|
73100-05-50
|
D-Dimer (Qual/semiQuant)
|
Qualitative or SemiQuantitative analysis of D-dimer Fibrin degradation products
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of D-dimer presence via qualitative or semiquantitative methods (e.g. immunochromatography)
| null | null | null |
731000560
|
73100-05-60
|
D-Dimer; Quant.
|
Quantitative analysis of D-dimer fibrin degradation products
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of D-dimer presence via quantitative methods (e.g. latex immunoassay)
| null | null | null |
731000570
|
73100-05-70
|
D-Dimer (Ultrasensitive)
|
Ultrasensitive (Qualitative or SemiQuantitative) analysis of D-dimer fibrin degradation products
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of D-dimer presence via ultrasensitive, qualitative or semiquantitative methods (e.g. ELFA; for venous thromboembolism)
| null | null | null |
731000580
|
73100-05-80
|
Fibrinogen activity
|
Measurement of fibrinogen activity
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of Fibrinogen Clotting Activity (e.g. abnormal bleeding or clotting)
| null | null | null |
731000590
|
73100-05-90
|
Fibrinogen antigen s
|
Measurement of fibrinogen antigens
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Fibrinogen Antigen presence
| null | null | null |
731000600
|
73100-06-00
|
Screening for coagulopathy report
|
Interpretation and report for coagulopathy screening
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Physician or non physician interpertation and report for range of tests performed for coagulaopathy screening
| null | null | null |
731000610
|
73100-06-10
|
Whole Blood Coagulation/Fibrinolysis w/ inter & report
|
Coagulation or fibrinolysis (clot break down) function measurement with interpretation and written report
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Physician interpertation of whole blood coagulation/fibrinolysis profile
| null | null |
Assign this code per day of service
|
731000620
|
73100-06-20
|
Functional assay Coagulation/Fibrinolysis NEC
|
Functional assay for coagulation/fibrinolysis unspecified chemical compound
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Functional activity test for unspecified biochemical compound related to coagulation/fibrinolysis (e.g. ADAMTS-13, other analytes)
| null | null |
Assign this code for each compound
|
731000630
|
73100-06-30
|
Fibrinolytic Plasmin
|
Measurement of plasmin fibrinolytic factor
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Plasmin activity
| null | null | null |
731000640
|
73100-06-40
|
Fibrinolytic Alpha-2 Antiplasmin
|
Measurement of Alpha-2 Antiplasmin Fibrinolytic factor
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of alpha-2 antiplasmin levels
| null | null | null |
731000650
|
73100-06-50
|
Fibrinolytic Plasminogen Activator
|
Measurement of Plasminogen Activator Fibrinolytic factor
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of plasminogen activator activity
| null | null | null |
731000660
|
73100-06-60
|
Fibrinolytic Plasminogen Excluding antigen ic
|
Measurement of Plasminogen Fibrinolytic factor (excluding antigenic assays)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of direct plasminogen levels (e.g. thrombosis, ligneous conjunctivitis)
| null | null | null |
731000670
|
73100-06-70
|
Fibrinolytic Plasminogen antigen ic
|
Measurement of Plasminogen Fibrinolytic factor (including antigenic assay)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of antigenic (i.e. measuring antibody concentration) plasminogen activity (e.g. thrombosis, ligneous conjunctivitis)
| null | null | null |
731000680
|
73100-06-80
|
Heinz Bodies (Direct)
|
Direct measurement of Heinz bodies
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Heinz bodies presence (e.g. hemolytic anemias, G6PD deficiency, alpha thalassemia, unstable hemoglobin, ingestion of certain drugs).
| null | null | null |
731000690
|
73100-06-90
|
Heinz bodies (Induced) by admin Acetyl phenylhydrazine
|
Induced measurement of Heinz bodies by administration of Acetyl phenylhydrazine
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Induced Measurement of Heinz bodies (e.g. unstable hemoglobins).
| null | null | null |
731000700
|
73100-07-00
|
Kleihauer's Betke test-Fetal
|
Assessment of fetal-maternal haemorrhage by differential lysis method
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Test for quantification of fetal RBC or hemoglobin (Rh+) mixing with maternal circulation (Rh-)
| null | null | null |
731000710
|
73100-07-10
|
Rosette test-Fetal
|
Assessment of fetal-maternal haemorrhage using the rosette method
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Test to determine wether fetal blood (Rh+) mixed with maternal maternal blood (Rh-)
| null | null | null |
731000720
|
73100-07-20
|
Hemolysin Acid
|
Analysis of blood specimen mixed with acid for hemolysis evaluation
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of red blood cells breakdown
| null | null | null |
731000730
|
73100-07-30
|
Heparin Concentration
|
Measurement of Heparin Concentration
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Assay for measuring amount of heparin
| null | null | null |
731000740
|
73100-07-40
|
Heparin Neutralization
|
Neutralization of Heparin
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Assay for neutralizing heparin (e.g. suspected heparin contamination, removal from heparinized lines samples as in neonates).
| null | null | null |
731000750
|
73100-07-50
|
Heparin-Protamine Tolerance test
|
Assay for Heparin-protamine tolerance
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Assay for heparin activity
| null | null | null |
731000760
|
73100-07-60
|
Iron Stain
|
Iron stain on peripheral blood smear sample
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Peripheral blood stain treated with iron stain to visulize red bloos cells siderotic granules (e.g. for impaired hemoglobin production, e.g. sickle cell)
| null | null | null |
731000770
|
73100-07-70
|
LAP test
|
Assay for Leukocyte Alkaline Phosphatase with count
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of leukocyte Alkaline phosphate levels with white blood cell count (e.g. leukemoid reaction or chronic granulocytic leukemia)
| null | null | null |
731000780
|
73100-07-80
|
RBC Mechanical Fragility
|
Measurement of RBC hemolysis susceptibility due to mechanical stress
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Measurement of RBC survival ability when subjected to mechanical stress
| null | null | null |
731000790
|
73100-07-90
|
Muramidase
|
Measurement of enzyme Muramidase levels
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of plasma Muramidase levels (e.g. for diagnosis of leukemias)
| null | null | null |
731000800
|
73100-08-00
|
Osmotic Fragility test (Unincubated)
|
Measurement of RBC hemolysis susceptibility due to osmotic stress; Unincubated
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Measurement of RBC survival ability when subjected to osmotic stress (e.g. spherocytosis, thalassemia)
| null | null | null |
731000810
|
73100-08-10
|
Osmotic Fragility test (Incubated)
|
Measurement of RBC hemolysis susceptibility due to osmotic stress; Incubated
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Measurement of RBC survival ability when subjected to osmotic stress; incubated in sodium chloride solution (e.g. spherocytosis, thalassemia)
| null | null | null |
731000820
|
73100-08-20
|
Platelet Aggregation test
|
In vitro platelet aggregation Assay; each chemical reagent
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of platetelt aggregation after additon of a certain chemical reagent to the specimen (e.g. low platelet count, bleeding disorders).
| null | null |
When different reagents are used, assign this code more than once
|
731000830
|
73100-08-30
|
Phospholipid Clotting time
|
Measurement of clotting time with addition of platelet phospholipid reagent
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Clotting time after addition of phospholipid reagent (e.g. detection of antiphospholipid antibodies )
| null | null | null |
731000840
|
73100-08-40
|
Hexagonal Phase Phospholipid
|
Measurement of clotting time with addition of hexagonal phospholipid reagent
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Coagulation time after addition of hexagonal phospholipid reagent (e.g. detection of antiphospholipid antibodies )
| null | null | null |
731000850
|
73100-08-50
|
Prothrombin time test
|
Measurement of Prothrombin clotting time
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of prothrombin time in plasma
|
INTERNatIonAL NorMALIZED RatIO ( INR )
| null | null |
731000860
|
73100-08-60
|
Plasma Fractions Clotting time
|
Measurement of clotting time with addition of plasma fractions
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Clotting time after addition of plasma fractions (e.g. Prolonged PT time )
| null | null |
Assign this code for each plasma fraction
|
731000870
|
73100-08-70
|
RVVT
|
Russell viper venom time (RVVT) test
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Clotting test of RVVT (e.g. screening for Lupus anticoagulants)
| null | null | null |
731000880
|
73100-08-80
|
DRVVT
|
Dilute Russell viper venom time (DRVVT)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Clotting test of dRVVT (e.g. screening for Lupus anticoagulants)
| null | null | null |
731000890
|
73100-08-90
|
Reptilase time (RT)
|
Plasma reptilase time (RT) clotting assay
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Evaluation of reptilase (venom extract enzyme) Impact on clotting time
| null | null | null |
731000900
|
73100-09-00
|
ESR (Manual)
|
Manual Measurement of Erythrocyte Sedimentation Rate
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Manual Determination of Erythrocyte sedimentation rate (e.g. to determine presence of inflammation)
|
SEDIMENTatIon RatE, ERYTHROCYTE; Non-AUtoMatED
| null | null |
731000910
|
73100-09-10
|
ESR (Automated)
|
Automated Measurement of Erythrocyte Sedimentation Rate
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Automated Determination of Erythrocyte sedimentation rate (e.g. to determine presence of inflammation)
| null | null | null |
731000920
|
73100-09-20
|
TT (Thrombin time)
|
Measurement of clotting time by thrombin reagent
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Clotting time after addition of thrombin reagent (e.g. for presence of heparin or similar anticoagulants)
| null | null | null |
731000930
|
73100-09-30
|
Thrombin time; titer
|
Measurement of clotting time using different thrombin reagent concentrations
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of Clotting time after addition of varying concentrations of thrombin reagent (e.g. for presence of heparin or similar anticoagulants)
| null | null | null |
731000940
|
73100-09-40
|
TTI test
|
Tissue Thrombin Inhibition (TTI) Test
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
TTI test for detection of lupus anticoagulants
| null | null | null |
731000950
|
73100-09-50
|
PTT (Partial Thromboplastin time)
|
Measurement of partial thromboplastin time (PTT) from plasma or whole blood
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of PTT using plasma/whole blood (e.g. bleeding disorders; monitoring anticoagulant therapy)
| null | null | null |
731000960
|
73100-09-60
|
PTT; Plasma Fractions
|
Measurement of partial thromboplastin time (PTT) by plasma fractions
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of PTT after addition of plasma fractions (e.g. bleeding disorders; monitoring anticoagulant therapy)
| null | null | null |
731000970
|
73100-09-70
|
Viscosity test
|
Measurement of Serum Viscosity Levels
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Viscosity test (e.g. hyperviscosity syndrome)
| null | null | null |
731000980
|
73100-09-80
|
Unlist hematology proc
|
Unlisted Hematology Procedure
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Unlisted Hematology procedure
| null | null | null |
731000990
|
73100-09-90
|
Febrile Agglutinin test
|
Measurement of antibody to infectious organism. (e.g. Brucella, Francisella, Murine typhus, Q fever, Rocky Mountain spotted fever)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Measurement of febrile agglutinins for infection detection (Widal’s test)
| null | null |
Assign this code for each tested antigen
|
731001000
|
73100-10-00
|
Allergen Specific IgG; Quant./Qual.
|
Quantitative/Semiquantitative measurement of antibody (IgG) to allergic substance
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Detection of allegren specific IgG in serum (e.g. food allergy, drug allergy, or environmental allergy)
| null | null |
Assign this code for each tested allergen
|
731001010
|
73100-10-10
|
Allergen Specific IgE; Quant./Qual.
|
Quantitative/Semiquantitative measurement of antibody (IgE) to allergic substance
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Detection of allegren specific IgE in serum (e.g. food allergy, drug allergy, or environmental allergy)
| null | null |
Assign this code for each crude allergen extract
|
731001020
|
73100-10-20
|
Qual. Allergen Specific IgE
|
Qualitative measurement of antibody (IgE) to allergic substance; Multiallergen Screen
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Detection of allegren specific IgE in serum by multiallergen screening tool (e.g. determination of allergen) (e.g. multiple radioallergosorbent tests(MAST))
| null | null | null |
731001030
|
73100-10-30
|
Allergen Specific IgE (recombinant/purified); Quant./Qual.
|
Quantitative/Semiquantitative measurement of antibody (IgE) to allergic substance using recombinant/purified components
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Detection of allegren specific IgE in serum by recombinant or purified components (e.g. determination of allergen)
| null | null | null |
731001040
|
73100-10-40
|
WBC (Leukocyte) Ab identification
|
Assay for white blood cells (Identification) antibodies (Identification)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Leukocyte antibody identification (e.g. infertility, transfusion reactions).
| null | null | null |
731001050
|
73100-10-50
|
Platelet Ab identification
|
Assay for platelets antibodies (Identification)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Platelet antibody identification (e.g. bruising, excessive bleeding, or a low platelet count).
| null | null | null |
731001060
|
73100-10-60
|
Platelet-Ig Ab identification
|
Assay for platelets associated immunoglobulins antibodies (Identification)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Pletelet associated immunoglobulins antibody identification (e.g. bruising, excessive bleeding, or a low platelet count).
| null | null | null |
731001070
|
73100-10-70
|
ANA
|
Measurement of antinuclear antibodies (ANA)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of ANA presence in serum (e.g suspecting autoimmune disorders)
|
ANTI LA (SSB)
ANTI RO (SSA)
| null |
Assign this code when results are reported qualitatively (positive/negative)
|
731001080
|
73100-10-80
|
ANA (Titer)
|
Measurement of antinuclear antibodies titer (ANA)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of ANA presence in serum titer (e.g suspecting autoimmune disorders)
| null | null |
Assign this code when results are reported as a ratio (e.g.1:320)
|
731001090
|
73100-10-90
|
ASO (Titer)
|
Measurement of Antistreptolysin O (ASO) with titer dilution
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of ASO presence in blood with titer (e.g. for streptococcus infection)
| null | null | null |
731001100
|
73100-11-00
|
ASO
|
Measurement of Antistreptolysin O (ASO)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of ASO presence in blood (e.g. for bacterial endocarditis, glomerulonephritis, rheumatic fever, scarlet fever, strep throat)
| null | null |
Assign this code when results are reported qualitatively (positive/negative)
|
731001110
|
73100-11-10
|
Cross Match
|
Crossmatch with physician interpretation and report due to difficult cross matching
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Laboratory perform Crossmatching of a specimen due to crossmatch difficulty from irregular antibodies or others; requiring blood bank physician interpretation and report
| null | null | null |
731001120
|
73100-11-20
|
Transfusion Reaction
|
Transfusion Reaction investigation with blood bank physician interpretation and report
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Transfusion reaction requiring blood bank physician interpretation and report
| null | null | null |
731001130
|
73100-11-30
|
BB Physician Authorization report
|
Blood Bank physician authorization for service deviation
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
The blood bank physician authorize the deviation from standard procedures for certain cases such as in the use of outdated blood or transfusion of Rh incompatible units
| null | null | null |
731001140
|
73100-11-40
|
CRP
|
Measurement of C Reactive Protein
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of C-reactive protein presence (eg. inflammatory diseases like rheumatoid arthritis)
| null | null | null |
731001150
|
73100-11-50
|
CRP H.S
|
Measurement of High sensitive C-reactive Protein (hs-CRP)
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
Determination of high sensitivity C-reactive protein presence (eg. inflammatory diseases like cardiovascular inflammatory conditions.)
| null | null | null |
731001160
|
73100-11-60
|
Beta 2 GlycoProtein I Ab
|
Assay for beta 2 glycoProtein antibodies
| 21
|
Laboratory and Pathology
| 3,100
|
Study of Blood Products & Antibodies
|
B2GP1 antibody identification (e.g. clotting)
|
BETA -2- GLYCOPROTEIN 1 ABS (IGM)
| null |
Assign this code for each tested antibody
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.